Showing results (11-20 of 60) with videos related to
Sort By:
Pageof 6
Journal of Clinical Pharmacology|October 2, 2014
Population pharmacokinetic modeling and simulation of amprenavir following fosamprenavir/ritonavir administration for dose optimization in HIV infected pediatric patientsApril M Barbour, Leonid Gibiansky, Mary Beth WireJournal of Pharmacokinetics and Pharmacodynamics|November 14, 2008
Approximations of the target-mediated drug disposition model and identifiability of model parametersLeonid Gibiansky, Ekaterina Gibiansky, Tarundeep Kakkar, et al.Journal of Pharmacokinetics and Pharmacodynamics|March 20, 2016
Model-based pharmacokinetic analysis of elotuzumab in patients with relapsed/refractory multiple myelomaLeonid Gibiansky, Chaitali Passey, Amit Roy, et al.CPT: Pharmacometrics & Systems Pharmacology|June 10, 2021
Population pharmacokinetic and exposure-response analyses of intravenous and subcutaneous rituximab in patients with chronic lymphocytic leukemiaEkaterina Gibiansky, Leonid Gibiansky, Clarisse Chavanne, et al.Journal of Pharmacokinetics and Pharmacodynamics|June 22, 2014
Methods to detect non-compliance and reduce its impact on population PK parameter estimatesLeonid Gibiansky, Ekaterina Gibiansky, Valerie Cosson, et al.Journal of Pharmacokinetics and Pharmacodynamics|February 15, 2022
Integrated multiple analytes and semi-mechanistic population pharmacokinetic model of tusamitamab ravtansine, a DM4 anti-CEACAM5 antibody-drug conjugateClemence Pouzin, Leonid Gibiansky, Nathalie Fagniez, et al.CPT: Pharmacometrics & Systems Pharmacology|November 23, 2023
Population PK/PD modeling of low-density lipoprotein cholesterol response in hypercholesterolemic participants following administration of bococizumab, a potent anti-PCSK9 monoclonal antibodyEllen Q Wang, Nitin Kaila, David Plowchalk, et al.Translational Vision Science & Technology|November 13, 2024
Ocular Pharmacokinetics of Faricimab Following Intravitreal Administration in Patients With Retinal DiseaseCheikh Diack, Leonid Gibiansky, Felix Jaminion, et al.Journal of Pharmacokinetics and Pharmacodynamics|January 25, 2012
Population pharmacodynamic modeling of various extended-release formulations of methylphenidate in children with attention deficit hyperactivity disorder via meta-analysisHolly Kimko, Ekaterina Gibiansky, Leonid Gibiansky, et al.British Journal of Clinical Pharmacology|May 4, 2019
Pharmacokinetics, exposure, efficacy and safety of obinutuzumab in rituximab-refractory follicular lymphoma patients in the GADOLIN phase III studyEkaterina Gibiansky, Leonid Gibiansky, Vincent Buchheit, et al.Pageof 6